Singapore markets closed

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6400-0.2500 (-6.43%)
At close: 04:00PM EDT
3.9500 +0.31 (+8.52%)
After hours: 07:24PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
78,323
111,272
85,061
57,155
24,005
-
Selling general and administrative
24,959
32,039
27,323
15,727
4,005
-
Total operating expenses
103,282
143,311
112,384
72,882
28,010
-
Operating income or loss
-103,282
-143,311
-112,384
-72,882
-28,010
-
Interest expense
-
-
-
-
-
1
Total other income/expenses net
336
-1,037
119
-1,122
-7,878
-
Income before tax
-101,159
-135,014
-108,501
-73,958
-35,879
-
Income tax expense
421
338
0
-
-
-
Income from continuing operations
-101,159
-135,352
-108,501
-73,958
-35,879
-
Net income
-101,159
-135,352
-108,501
-73,958
-35,879
-
Net income available to common shareholders
-101,159
-135,352
-108,501
-73,958
-35,879
-
Basic EPS
-2.30
-2.63
-2.30
-2.96
-1.65
-
Diluted EPS
-2.30
-2.63
-2.30
-2.96
-1.65
-
Basic average shares
47,227
51,397
47,227
25,000
21,738
-
Diluted average shares
47,227
51,397
47,227
25,000
21,738
-